March 30, 2020
Easy to use, palm-sized system will enable broader use across healthcare facilities closer to the patients and will begin shipping immediately
Read more →
August 1, 2019
Mesa Biotech Inc. is a privately-held, molecular diagnostic company that has developed the Accula™ System, an affordable, sample-to-answer, CLIA-waived PCR (polymerase chain reaction) testing platform designed specifically for point-of-care (POC) infectious disease diagnosis
Read more →
Sign-up for the Weekly Newsletter from FDA Reporter.